Back to Selection     Print       Date : 30 Jun 2026
Fund Summary
Nippon India Pharma Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 05-Jun-04
Corpus(Cr.) 9044.0 Latest NAV 571.2438 As on 29-07-2026
Equity(%) 97.64 52 Week High 571.244
Debt(%) 2.36 52 Week Low 481.825
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.51
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Sailesh Raj Bhan
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 38.52%
Top 10 Holdings 58.09%
Top 25 Holdings 90.53%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 72.47
Healthcare 21.99
Retail 3.18
Cash 2.36
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.55
PE Ratio 38.70
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 12.78
Lupin Limited 7.45
Dr Reddys Laboratories Limited 6.68
Cipla Limited 6.15
DIVI LABORATORIES LTD 5.46
Apollo Hos Ent Ltd 5.27
Mankind Pharma Limited 4.03
Sai Life Sciences Limited 3.49
Ajanta Pharma Limited 3.46
Max Healthcare Institute Limited 3.32
MedPlus Health Services Limited 3.18
Vijaya Diagnostic Centre Limited 2.80
Thyrocare Technologies Limited 2.65
IPCA Laboratories Limited 2.57
GLAXO SMITHKLINE PHARMA 2.47
Triparty Repo 2.30
Gland Pharma Limited 2.21
Abbott India Limited 2.09
Alkem Laboratories Limited 1.99
Dr Lal Path Labs Ltd 1.85
Narayana Hrudalaya Ltd 1.80
Aurobindo Pharma Limited 1.75
Syngene International Limited 1.70
Pfizer Limited 1.56
Emcure Pharmaceuticals Limited 1.52

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
3.23% 10.42% 18.56% 6.66%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.46% 0.94% -3.91% -1.20%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
3.81% 12.06% 21.63% 11.52%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
8.51% 18.60% 13.34% 14.95%
 
 
0.01% 8.55% 10.25% 12.21%
 
 
10.97% 20.91% 14.75% 10.84%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Nippon India Pharma Fund (G) 15.22% 0.9512 10.6963% 45.5902 0.1359
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Nippon India Pharma Fund (G) 13.2820% 0.0002 0.2661 14.6406 1.0434
 
Back to Selection